成人颈部肿块评估临床实践指南
该指南由耳鼻咽喉头颈外科领域制定,针对≥18岁成人颈部肿块患者,提出系列推荐以促进及时诊断。核心推荐包括:对怀疑恶性者行增强颈部CT或MRI;根据病史(≥2周无消退)和体检特征(固定、质硬、>1.5cm、溃疡)识别高危患者;高危者行细针穿刺而非开放活检;不常规使用抗生素。
要点
- 成人颈部肿块应视为潜在恶性直至证实,尤其持续性肿块。
- 高危标准:无感染史且肿块≥2周无显著变化,或体检有固定、质硬、>1.5cm、溃疡。
- 高危患者首选增强颈部CT或MRI,诊断不明时行细针穿刺。
核心结论
- 成人颈部肿块应被视为恶性直至排除,及时诊断对改善预后至关重要。
- 指南推荐对高危患者行增强影像和细针穿刺,避免开放活检。
研究设计与样本
- 指南制定机构为耳鼻咽喉头颈外科相关学会,方法基于证据评价形成推荐。
- 目标人群为≥18岁颈部肿块患者,目标临床医生包括首诊医生、牙医、急诊医生、病理和放射医生。
主要发现
- 成人持续性颈部肿块多为肿瘤,恶性远超其他病因。
- 无症状颈部肿块可能是头颈癌(如鳞状细胞癌、淋巴瘤、甲状腺或涎腺癌)的首发表现。
- 诊断延迟常见,直接影响肿瘤分期和预后。
关键数值与推荐
- 高危标准:无感染史且肿块≥2周无显著波动,或 duration 不确定。
- 体检高危特征:固定于邻近组织、质硬、大小>1.5 cm、表面皮肤溃疡。
- 强烈推荐高危患者行增强颈部CT或MRI。
- 高危且诊断不明时行细针穿刺而非开放活检。
- 不常规推荐抗生素治疗,除非有细菌感染征象。
临床怎么用
- 首诊医生应识别高危颈部肿块患者并评估病史和体检特征。
- 对高危患者安排增强影像,必要时细针穿刺,并转诊头颈癌专科。
- 对低危患者告知需进一步评估的指征并制定随访计划。
局限性
- 指南不适用于儿童。
- 不涵盖已知源于甲状腺、涎腺、下颌或牙科病变的肿块管理。
- 不涉及特定病理类型的后续治疗。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Objective Neck masses are common in adults, but often the underlying etiology is not easily identifiable. While infections cause most of the neck masses in children, most persistent neck masses in adults are neoplasms. Malignant neoplasms far exceed any other etiology of adult neck mass. Importantly, an asymptomatic neck mass may be the initial or only clinically apparent manifestation of head and neck cancer, such as squamous cell carcinoma (HNSCC), lymphoma, thyroid, or salivary gland cancer. Evidence suggests that a neck mass in the adult patient should be considered malignant until proven otherwise. Timely diagnosis of a neck mass due to metastatic HNSCC is paramount because delayed diagnosis directly affects tumor stage and worsens prognosis. Unfortunately, despite substantial advances in testing modalities over the last few decades, diagnostic delays are common. Currently, there is only 1 evidence-based clinical practice guideline to assist clinicians in evaluating an adult with a neck mass. Additionally, much of the available information is fragmented, disorganized, or focused on specific etiologies. In addition, although there is literature related to the diagnostic accuracy of individual tests, there is little guidance about rational sequencing of tests in the course of clinical care. This guideline strives to bring a coherent, evidence-based, multidisciplinary perspective to the evaluation of the neck mass with the intention to facilitate prompt diagnosis and enhance patient outcomes. Purpose The primary purpose of this guideline is to promote the efficient, effective, and accurate diagnostic workup of neck masses to ensure that adults with potentially malignant disease receive prompt diagnosis and intervention to optimize outcomes. Specific goals include reducing delays in diagnosis of HNSCC; promoting appropriate testing, including imaging, pathologic evaluation, and empiric medical therapies; reducing inappropriate testing; and promoting appropriate physical examination when cancer is suspected. The target patient for this guideline is anyone ≥18 years old with a neck mass. The target clinician for this guideline is anyone who may be the first clinician whom a patient with a neck mass encounters. This includes clinicians in primary care, dentistry, and emergency medicine, as well as pathologists and radiologists who have a role in diagnosing neck masses. This guideline does not apply to children. This guideline addresses the initial broad differential diagnosis of a neck mass in an adult. However, the intention is only to assist the clinician with a basic understanding of the broad array of possible entities. The intention is not to direct management of a neck mass known to originate from thyroid, salivary gland, mandibular, or dental pathology as management recommendations for these etiologies already exist. This guideline also does not address the subsequent management of specific pathologic entities, as treatment recommendations for benign and malignant neck masses can be found elsewhere. Instead, this guideline is restricted to addressing the appropriate work-up of an adult patient with a neck mass that may be malignant in order to expedite diagnosis and referral to a head and neck cancer specialist. The Guideline Development Group sought to craft a set of actionable statements relevant to diagnostic decisions made by a clinician in the workup of an adult patient with a neck mass. Furthermore, where possible, the Guideline Development Group incorporated evidence to promote high-quality and cost-effective care. Action Statements The development group made a strong recommendation that clinicians should order a neck computed tomography (or magnetic resonance imaging) with contrast for patients with a neck mass deemed at increased risk for malignancy. The development group made the following recommendations: (1) Clinicians should identify patients with a neck mass who are at increased risk for malignancy because the patient lacks a history of infectious etiology and the mass has been present for ≥2 weeks without significant fluctuation or the mass is of uncertain duration. (2) Clinicians should identify patients with a neck mass who are at increased risk for malignancy based on ≥1 of these physical examination characteristics: fixation to adjacent tissues, firm consistency, size >1.5 cm, or ulceration of overlying skin. (3) Clinicians should conduct an initial history and physical examination for patients with a neck mass to identify those with other suspicious findings that represent an increased risk for malignancy. (4) For patients with a neck mass who are not at increased risk for malignancy, clinicians or their designees should advise patients of criteria that would trigger the need for additional evaluation. Clinicians or their designees should also document a plan for follow-up to assess resolution or final diagnosis. (5) For patients with a neck mass who are deemed at increased risk for malignancy, clinicians or their designees should explain to the patient the significance of being at increased risk and explain any recommended diagnostic tests. (6) Clinicians should perform, or refer the patient to a clinician who can perform, a targeted physical examination (including visualizing the mucosa of the larynx, base of tongue, and pharynx) for patients with a neck mass deemed at increased risk for malignancy. (7) Clinicians should perform fine-needle aspiration (FNA) instead of open biopsy, or refer the patient to someone who can perform FNA, for patients with a neck mass deemed at increased risk for malignancy when the diagnosis of the neck mass remains uncertain. (8) For patients with a neck mass deemed at increased risk for malignancy, clinicians should continue evaluation of patients with a cystic neck mass, as determined by FNA or imaging studies, until a diagnosis is obtained and should not assume that the mass is benign. (9) Clinicians should obtain additional ancillary tests based on the patient's history and physical examination when a patient with a neck mass is deemed at increased risk for malignancy who does not have a diagnosis after FNA and imaging. (10) Clinicians should recommend evaluation of the upper aerodigestive tract under anesthesia, before open biopsy, for patients with a neck mass deemed at increased risk for malignancy and without a diagnosis or primary site identified with FNA, imaging, and/or ancillary tests. The development group recommended against clinicians routinely prescribing antibiotic therapy for patients with a neck mass unless there are signs and symptoms of bacterial infection.
引用
- Pynnonen MA, Gillespie MB, Roman B, et al. Clinical Practice Guideline: Evaluation of the Neck Mass in Adults. Otolaryngol Head Neck Surg. 2017. PMID: 28891406. doi:10.1177/0194599817722550
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。